RET and thyroid gland carcinoma: At variance with these results, metformin did not affect the TNF-α-stimulated secretion of CXCL8 in thyroid cancer cell lines harboring the RET/PTC rearrangement or the BRAF V600e mutation (TPC-1 and BCPAP cells, resp).